Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Share News (CSRT)

  • There is currently no data for CSRT

Bwin.party non-exec makes double purchase

Tue, 19th Mar 2013 15:59
bwin.party digital entertainment announced Tuesday that one of its Non-Executive Directors has made two purchases following a report by the company admitting profits had suffered a sharp decline. Geoff Baldwin on Friday purchased 226,000 shares at 147.83p, followed by a further 74,000 on Monday at 148.02p. Together the transactions cost the director £443,631. The group said Friday that clean earnings before interest, tax, depreciation and amortisation fell 17% year-on-year from €199.3m to 164.9m to reflect flat revenue, increased gaming taxes and compliance costs. The company was hit by the introduction of a 5.0% turnover tax on sports betting in its core market of Germany in July, though it said that the majority was passed on to customers. bwin.party registered a loss before tax of €23.5m for 2012, significantly lower than the €422.9m loss made in 2011, mainly due to a sharp decrease in impairment losses. Nevertheless, the final dividend was raised by 10% to 1.72p per share, bringing the total payout for 2012 to 3.44p per share, up from 3.12p previously.Top Director BuysObtala Resources (OBT) Director name: Mr Simon RollasonAmount purchased: 221,260 @ 903.00p Value: £1,997,978Bwin.party Digital Entertainment (BPTY) Director name: Mr Geoff Baldwin Amount purchased: 226,000 @ 147.83p Value: £334,096Bwin.party Digital Entertainment (BPTY) Director name: Mr Geoff Baldwin Amount purchased: 74,000 @ 148.02p Value: £109,535Alliance Trust (ATST)Director name: Mr Win RobbinsAmount purchased: 11,544 @ 430.60p Value: £49,708Consort Medical (CSRT) Director name: Mr Richard CottonAmount purchased: 3,894 @ 765.00p Value: £29,789PureCircle Ltd. (DI) (PURE) Director name: Mr William MitchellAmount purchased: 10,000 @ 252.00p Value: £25,200UBM (UBM) Director name: Dame Helen AlexanderAmount purchased: 2,000 @ 712.26p Value: £14,245Top Director SellsAbcam (ABC) Director name: Dr Jonathan MilnerAmount sold: 974,000 @ 450.50p Value: £4,387,870Jardine Matheson Holdings Ltd (Singapore Reg) (JAR) Director name: Mr Benjamin KeswickAmount sold: 20,000 @ $65.58 Value: $1,311,684UBM (UBM) Director name: Mr Robert Gray Amount sold: 38,430 @ 710.88p Value: £273,191

Related News

Jardine Matheson sets USD500 million buyback as new CEO sets out plans
1 day ago

Jardine Matheson sets USD500 million buyback as new CEO sets out plans

(Alliance News) - Jardine Matheson Holdings Ltd on Tuesday set out its 2030 objectives at what the 194-year-old company called its "first ever" invest...

LONDON BRIEFING: Rathbones takes regulatory hit; boohoo narrows loss
1 day ago

LONDON BRIEFING: Rathbones takes regulatory hit; boohoo narrows loss

(Alliance News) - Rathbones flags a GBP60 million regulatory remediation charge, while International Workplace Group and Hilton Food Group unveil lead...

IN BRIEF: Jardine Matheson CEO buys shares worth USD2.9 million
27 May 2026

IN BRIEF: Jardine Matheson CEO buys shares worth USD2.9 million

Jardine Matheson Holdings Ltd - Hong Kong-based holding company with interests in retail, property, hotels and motor dealerships - Chief Executive Lin...

CSRT.L News

Recipharm Holds 91% Consort Stake, To Implement Compulsory Acquisition
17 Feb 2020

Recipharm Holds 91% Consort Stake, To Implement Compulsory Acquisition

Recipharm Holds 91% Consort Stake, To Implement Compulsory Acquisition

Monday broker round-up
10 Feb 2020

Monday broker round-up

(Sharecast News) - Consort Medical: RBC Capital Markets upgrades to sector performer with a target price of 1,010p.

Recipharm Lowers Acceptance Condition; Consort Offer Now Unconditional
4 Feb 2020

Recipharm Lowers Acceptance Condition; Consort Offer Now Unconditional

Recipharm Lowers Acceptance Condition; Consort Offer Now Unconditional

Recipharm To Make No Further Changes To Consort Medical Offer
29 Jan 2020

Recipharm To Make No Further Changes To Consort Medical Offer

Recipharm To Make No Further Changes To Consort Medical Offer

Recipharm Extends Consort Medical Offer Deadline To February 4
24 Jan 2020

Recipharm Extends Consort Medical Offer Deadline To February 4

Recipharm Extends Consort Medical Offer Deadline To February 4

Recipharm Buys 10% Of Takeover Target Consort Medical
22 Jan 2020

Recipharm Buys 10% Of Takeover Target Consort Medical

Recipharm Buys 10% Of Takeover Target Consort Medical

Recipharm's Consort Medical Takeover Clears German Regulatory Hurdle
14 Jan 2020

Recipharm's Consort Medical Takeover Clears German Regulatory Hurdle

Recipharm's Consort Medical Takeover Clears German Regulatory Hurdle

Friday broker round-up
10 Jan 2020

Friday broker round-up

(Sharecast News) - Polymetal International: Berenberg upgrades to buy with a target price of 1,480p.